Generex Awarded New Patent in Morocco

14-Apr-2009 - Morocco

Generex Biotechnology Corporation announced that it has received a new patent in Morocco. The Moroccan Industrial and Commercial Property Office granted the Company its first Moroccan patent, titled "Orally Absorbed Pharmaceutical Formulation and Method of Administration." The patent contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral membranes as well as device and method claims.

"While our regulatory scope in the Middle East region expands, the granting of this application in Morocco is a timely one," said Rose Perri, the Company's Chief Operating Officer. “We look forward to other patent grants that will augment the value of our increasing intellectual property portfolio.”

Generex currently holds an aggregate of 143 patents worldwide (21 of which are United States patents) and has an aggregate of 119 patent applications pending in various jurisdictions.

Other news from the department research and development

These products might interest you

Hydrosart® Ultrafilter

Hydrosart® Ultrafilter by Sartorius

Efficient ultrafiltration for biotech and pharma

Maximum flow rates and minimum protein loss with Hydrosart® membranes

ultra-filtration membranes
Hydrosart® Microfilter

Hydrosart® Microfilter by Sartorius

Hydrophilic microfilters for bioprocesses

Minimal protein adsorption and high flow rates

microfilters
Sartopore® Platinum

Sartopore® Platinum by Sartorius

Efficient filtration with minimal protein adsorption

Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"

filter membranes
Polyethersulfone Ultrafilter

Polyethersulfone Ultrafilter by Sartorius

Reliable filtration with PESU membranes

Perfect for biotechnology and pharmaceuticals, withstands sterilisation and high temperatures

membrane filters
Polyethersulfone Microfilter

Polyethersulfone Microfilter by Sartorius

Biotechnological filtration made easy

Highly stable 0.1 µm PESU membranes for maximum efficiency

microfilters
Sartobind® Rapid A

Sartobind® Rapid A by Sartorius

Efficient chromatography with disposable membranes

Increase productivity and reduce costs with fast cycle times

membranes
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Images of antibodies working together against malaria

Images of antibodies working together against malaria

Chemie.DE Information Service's 10th Anniversary: an Online Success Story

Chemie.DE Information Service's 10th Anniversary: an Online Success Story

Evocatal GmbH Closes New Financing Round

Eppendorf opens new site in Singapore - Targeted strengthening of customer focus with high-tech laboratory for pipette calibration
and extensive range of high-quality laboratory services

Eppendorf opens new site in Singapore - Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services

Evotec enters partnership with Vienna start-up - Quantro exploits innovative functional-genetic and transcriptomic technologies to address “undruggable” targets

Evotec enters partnership with Vienna start-up - Quantro exploits innovative functional-genetic and transcriptomic technologies to address “undruggable” targets

BluCon Biotech and LG Chem enter into unique investment agreement - BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

BluCon Biotech and LG Chem enter into unique investment agreement - BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

Antibiotic ribosomal compounds deciphered - Combating multidrug-resistant bacteria through high-resolution structural imaging

Antibiotic ribosomal compounds deciphered - Combating multidrug-resistant bacteria through high-resolution structural imaging

Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement - Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing

CT Atlantic AG Announces Appointment of Michael Höcker to CEO - Cara Lerner joins CT Atlantic as COO

Natural substances show promise against coronavirus - X-ray screening identifies compounds blocking a major corona enzyme

Natural substances show promise against coronavirus - X-ray screening identifies compounds blocking a major corona enzyme

Welichem Obtains Approval for Phase IIa Clinical Trial on Eczema

Affitech A/S signs research agreement with UT Southwestern to support further development of its lead antibody drug candidate AT001/r84